Inactivation of Rb and p53 tumor suppressor pathways enables preneoplastic cells with telomere dysfunction to emerge from crisis [4]; subsequent activation of TERT by a variety of mechanisms prevents further telomere shortening during late stages of malignant transformation, and in established cancers [31], [32], [41], [42]. The gene discussed is TP53; the disease is cancer.